ABSTRACT
自国家卫生健康委员会办公厅、国家中医药管理局办公室2020年1月27日印发《新型冠状病毒感染的肺炎诊疗方案(试行第四版)》以来,其中医治疗部分得到了广泛关注。第四版方案中的中医方案是基于专家组对来自武汉不同定点医院100余例发热门诊、急诊留观及住院患者的临床实地观察在上一版基础上修订而成,代表中医对疾病不同分期、不同程度、不同转归以及应对策略有了更深刻认识。如首次增加了基于时间轴的分期治疗、设立了“医学观察期”并推荐了防治方案、首次增加并推荐了方药剂量、增加了中成药推荐等。为进一步指导和规范中医方案的临床应用,专家组特从修订过程、修订内容、方案释义与说明建议等方面进行了详细解读,供临床中医师、中西医结合医师参考使用。
ABSTRACT
江夏方舱医院是武汉唯一一家中医方舱医院，医院以中医为主、中医药疗法全覆盖的方式运行，于2月14日开舱，运行26日，共收治新型冠状病毒肺炎患者564例，无一例转重症，获得零死亡、零转重、零复阳、零回头、零感染（包括医护人员、后勤安保人员）、零投诉的好成绩。医院在给予患者统方（“新冠2号”“新冠3号”）基础上，针对患者“发热”“咳嗽”“无特殊症状”“焦虑失眠”症状分别给予中药协定处方，再灵活选用针灸、外治、温灸、耳压、经络拍打等手段缓解不同患者的病痛，同时结合养生功法帮助康复，心理疏导调畅情志，最终获得了很好的疗效。“三因司天方”“太极六气针法”的使用对于病毒转阴起到了一定的作用，对于便血、疼痛、失眠等症状甚至有立竿见影的效果。
ABSTRACT
通过梳理中医对疫病的认识,对比分析我国近20年经历的较大疫病,认为2019年12月暴发的新型冠状病毒感染的呼吸道疾病(COVID-19)当以“湿毒疫”论治。随着疫情的蔓延,病例数逐渐增多,病患临床表现及发病规律逐渐清晰,发现此次疫病早期临床表现为发热或不发热,发热者多身热不扬、干咳、乏力、伴呕恶、便溏腹泻等消化系统疾病症状,舌苔普遍腻,具有明显的湿毒裹挟之症,病位在肺与脾。从病程看,多数发病缓慢,潜伏期长,症状相对温和,少数患者可加速发展为痰瘀壅肺、邪毒闭肺、内闭外脱等证候,此期重症转危重症呈现黏腻胶着、缠绵难愈的典型湿毒特点,病毒转阴后的恢复期多呈现邪气留恋、余热未清的特点,尤其是重症患者免疫功能和组织损伤的修复需要很长时间
ABSTRACT
By reviewing the understanding of epidemic diseases in traditional Chinese medicine (TCM), comparing and analyzing the major epidemic diseases experienced in China in the past 20 years, it is believed that the coronavirus disease 2019 (COVID-19) outbreak in December 2019 should be treated as “dampness-toxicity plagues”. With the spread of the epidemic, the number of cases gradually increasing, and the clinical manifestations and onset regularity of the patients gradually becoming clear, it was found that early clinical manifestations of the disease were fever or no fever and fever often being accompanied by multiple symptoms of hiding fever, dry cough, fatigue, vomiting, loose stools, diarrhea and other digestive symptoms. The tongue coating is generally greasy, and has obvious dampness-toxicity into the disease, and the disease is located in the lung and the spleen. The majority of patients were with slow onset, long incubation period, and relatively mild symptoms, while a few patients could rapidly develop into syndromes such as phlegm and blood stasis obstructing the lung, pathogen and poison blocking the lung, and inner blocking causing collapse etc. ,among whom severe to critical illness cases presented characteristics of the typical dampness-toxicity such as being sticky, difficult to cure. The convalescence period after the virus turns negative presented the characteristics of repeated pathogenic qi and lingering heat, and in particular, the repair of immune functions and tissue damage in severe patients needed to take a long time. SARS,2009 H1N1 Flu and COVID-19 were compared and analyzed, and it was believed that the epidemic diseases in modern times were mostly dampness, especially the current one. Therefore, the role of TCM should be brought into full play in the process of prevention and treatment, and we should pay attention to the treatment according to the syndrome based on eliminating dampness, detoxication, eliminating dirt and resolving turbidity.
通过梳理中医对疫病的认识,对比分析我国近20年经历的较大疫病,认为2019年12月暴发的新型冠状病毒肺炎当以"湿毒疫"论治。随着疫情的蔓延,病例数逐渐增多,病患临床表现及发病规律逐渐清晰,发现此次疫病早期临床表现为发热或不发热,发热者多身热不扬、干咳、乏力,伴恶心、呕吐、便溏、腹泻等消化系统症状,舌苔普遍腻,具有明显的湿毒裹挟之症,病位在肺与脾。多数患者发病缓慢,潜伏期长,症状相对温和,少数患者可迅速发展为痰瘀壅肺、邪毒闭肺、内闭外脱等证,此期重症转危重症呈现黏腻胶着、缠绵难愈的典型湿毒特点,病毒转阴后的恢复期多呈现邪气留恋、余热未清的特点,尤其是重症患者免疫功能和组织损伤的修复需要很长时间。比较分析了传染性非典型性肺炎、甲型H1N1流感及新型冠状病毒肺炎,认为近代流行疫病多湿,此次疫情尤为明显。因此,在防治过程中应充分发挥中医药作用,注意在化湿解毒、辟秽化浊的基础上因证施治。
ABSTRACT
Coronavirus disease 2019 ( COVID-19) belongs to the category of “epidemic disease”in traditional Chinese medicine， and treatment of integrated traditional Chinese and western medicine has clear efficacy． For ordinary patients， integrated traditional Chinese and western medicine can improve symptoms， shorten the course of treatment， and promote healing;for severe and critical patients， it can reduce lung exudation， control excessive inflammative reaction prevent the disease from worsening;for patients during convalescence， it can eliminate residual pathogenic factor， strengthen vital qi， and promotes the process of rehabilitation
新型冠状病毒肺炎属于中医学“疫病”范畴,中西医结合治疗具有明确疗效。对于普通型患者,中西医结合治疗可改善症状,缩短疗程,促进痊愈
ABSTRACT
Most of the patients with the new coronavirus (2019-ncov) pneumonia in wuhan had hinding fever, cough, weakness, poor appetite and greasy tongue coating as the main symptoms. According to the collected four diagnosis information, the cause of the disease was examined and the core pathogenesis was determined. It was considered that 2019-ncov pneumonia belonged to the category of plague, and the main disease was wet virus, which can be called wet virus epidemic. The disease is located in the lung and spleen, and the basic pathogenesis is "dampness, poison, stasis and closure". It needs to differentiate with cold, wind temperature, winter temperature and other diseases. According to the rule of disease transmission and change, it can be divided into four stages: early stage, progressive stage, extreme stage (critical stage) and convalescence stage. Most of the cases were in the early and progressive stages, which were the downstream (normal) of the disease. Symptoms such as extreme fatigue, wheezing, hemoptysis, etc., indicated that the disease would be aggravated by the adverse transmission, and the lung lesions are severe with wheezing and breathing difficulties, which was the reverse transmission and change of the disease. The treatment method is designed to eliminate filth and turbid, with eliminating evil spirits as the first key, and separating heat and promote air as the main, holding the early, progressive treatment is the key to reduce the critical illness, reduce the fatality rate.
武汉新型冠状病毒(2019-nCoV)肺炎大部分患者以身热不扬、咳嗽、乏力、纳差、舌苔厚腻为主要症状,根据采集的四诊信息,审症求因,研判核心病机,认为2019-nCoV感染肺炎属于瘟疫范畴,主要病性为湿毒,可称之为湿毒疫。病位在肺脾,基本病机特点为“湿、毒、瘀、闭”。本病需要与当令的时行感冒、风温、冬温等病证相鉴别。根据疾病传变规律,可分四个阶段辨治:早期、进展期、极期(危重期)、恢复期。大部分病例以早期、进展期为主,为本病的顺传(正局),极度乏力、喘憋、咯血等症状提示病情将逆传加重,肺之化源绝而喘脱,为本病的逆传和变局。治则治法拟为辟秽化浊,以祛邪为第一要义,以分消湿热、宣畅气机为主,把住早期、进展期治疗是减少危重症、降低病死率的关键。
ABSTRACT
Novel coronavirus-infected pneumonia belongs to the category of TCM epidemics. Since the outbreak, China's health administration has issued a series of "Pneumonitis Diagnosis and Treatment Programs for New Coronavirus Infection" (referred to as the "National Plan"), calling for the active role of traditional Chinese medicine to strengthen Integrated Traditional Chinese and Western Medicine. In China, 24 provinces, municipalities, and autonomous regions have released the "New Coronary Virus Infection Pneumonia Prevention Program" (referred to as the "Regional" Program ")" on the basis of the National "Program", combining regional and population characteristics. Viral pneumonia is differentiated and classified according to syndrome types and stages, and it provides a wealth of Chinese medicine prevention and treatment programs. In order to understand the epidemic situation in depth and provide a reference for TCM to respond quickly to similar epidemics, this study comprehensively collected and sorted out relevant information, and systematically analyzed the TCM prevention and control programs in various regions. Deficiency "has several characteristics. The disease is located in the lungs, which consumes righteousness, damages the spleen and lungs, and even shuts down. The "Plan" in each region basically adopts different measures according to the three stages of prevention, treatment and recovery. The prevention stage is mainly based on the Qi-solidifying tables such as Yupingfeng San, the treatment period is mainly based on clearing heat, dampness, detoxification and rescuing. Nourishing Yin.
新型冠状病毒感染的肺炎属于中医疫病范畴,疫情发生以来,我国卫生管理部门发布了系列《新型冠状病毒感染的肺炎诊疗方案》(简称“国家《方案》”),要求积极发挥中医药作用,加强中西医结合。我国先后有24个省市自治区在国家《方案》基础上,结合区域和人群特点,发布了本地区的《新型冠状病毒感染的肺炎防治方案》(简称“地区《方案》”),对新型冠状病毒肺炎进行辨证分型、分期,并提供了丰富的中医药防治方案。为了深入了解此次疫情并为中医药快速应对同类疫情提供参考,本研究全面收集并整理相关信息,系统分析了各地区中医药防治方案,认为该次疫病主要体现为“湿、热、毒、虚”几个特点,病位在肺,耗伤正气,损及脾肺,甚者窍闭神昏。各地区《方案》基本按照预防、治疗、恢复三个阶段采取不同措施,预防阶段以玉屏风散等益气固表为主,治疗期以清热化湿解毒救逆为主,恢复期则益气养阴为主。
ABSTRACT
Objective novel coronavirus pneumonia in the early stage of TCM syndrome characteristics and time distribution, and summarize the experience of TCM diagnosis and treatment. Methods novel coronavirus pneumonia patients in 608 outpatients and emergency department in Wuhan Hospital of traditional Chinese medicine were collected and analyzed retrospectively. Results the main clinical manifestations of 608 patients were fever (77.9%), muscle soreness (64.1%), cough (50.8%), chest tightness (46.9%), fatigue (44.1%), headache (41.6%), aversion to cold (38.7%) and anorexia (36.7%). In December 2019 and January 2020, 83.2% and 54.3% of the patients complained of fever and respiratory symptoms (cough and chest tightness), The proportion of patients with digestive system (nausea, vomiting, diarrhea, anorexia) as the main complaint was 0.9% and 17.3% respectively, while the proportion of patients with both was 15.9% and 28.4% respectively. Conclusion at the beginning of the epidemic, it may be a febrile disease, which is mainly caused by wind and temperature. The pathogenesis is that the pathogenic factors of warming enter the lung, and the lung fails to spread and cause lung qi stagnation. The four methods of "clearing, clearing, harmonizing and dissolving" are used as the treatment principle, and the effect is obvious. Later, due to the abnormal changes of local climate and its natural regional characteristics, the combination of temperature and miscellaneous Qi "dampness evil" between heaven and earth formed "dampness toxin and pestilence evil". The pathogenesis evolved into dampness evil trapping spleen, and Lung Qi was confined by dampness pathogen. The Qi mechanism was not smooth. The treatment should be to release lung detoxification, transport spleen to remove dampness, and timely use the method of "sweat" and "Xiaxia".
目的 探讨新型冠状病毒肺炎的早期中医临床证候特点和时间分布规律,并总结中医诊疗经验。方法 采用回顾性研究,搜集608例在武汉市中医医院门诊和急诊就诊的临床确诊新型冠状病毒肺炎患者的病历资料,通过描述性分析探讨中医证候分布规律及不同就诊时间的分布变化。结果 608例患者以发热(77.9%)、肌肉酸痛(64.1%)、咳嗽(50.8%)、胸闷憋气(46.9%)、乏力(44.1%)、头痛(41.6%)、恶寒(38.7%)、纳差(36.7%)为主要临床表现
ABSTRACT
Objective To investigate the clinical efficacy of integrated traditional Chinese and western medicine in the treatment of novel coronavirus pneumonia ( COVID-19) by retrospectively analyzing the clinical records of 52 patients． Methods The data of patients with COVID-19 from Hubei Provincial Hospital of Integrated Traditional Chinese and Western Medicine during January 15th， 2020 to February 8th， 2020 were collected to investigate and analyze the basic information， traditional Chinese medical syndromes， laboratory tests and treatment methods． Patients were divided into two groups according to the intervention， a western medicine group of 18 cases treated with antivirus， anti-infection and auxiliary supportive drugs， and an integrated treatment group of 34 cases treated with traditional Chinese medicine decoctions， patent Chinese medicines and traditional Chinese medicine injections in addition to the western medicine group． Clinical symptoms disappearance time， body temperature normalization time， accompanying symptom disappearance rate， average hospitalization days， clinical cure rate， and mortality rate were compared between groups． Ｒesults The 52 patients include 23 male patients and 29 female patients， the average age was ( 54. 00 ± 12. 83) years old， and the time from onset to hospitalization was ( 7. 44 ± 2. 99) days． The main symptoms include fever ( 75% ) ， fatigue ( 61. 5% ) ， cough ( 50% ) ， and other symptoms ( 34. 6% ) ． According to the conditions at the time of admission， there were 76. 9% ordinary type， 19. 2% severe patients， and 3. 8% critical patients． The main syndrome types in Chinese medicine were dampness-toxin stagnated in the lung ( 30. 8% ) ， pestilence-toxicity blocking the lung ( 25. 0% ) ， damp-heat accumulation toxin in the lung ( 21. 2% ) ， pathogenic heat congesting in the lung ( 19. 2% ) and internal blockade and external collapse ( 3. 8% ) ． Laboratory testing showed the following results: lymphocytes percentage ( 18. 53 ± 11. 01 ) % ， serum amyloid A ( 111. 65 ± 76. 98 ) mg /L， C-reaction protein ( 31. 34 ± 21. 99) mg /L and erythrocyte sedimentation rate ( 22. 60 ± 15. 65) mm /H． The clinical symptom disappearance time ［( 5. 15 ± 1. 68) d］， body temperature recovery time ［( 2. 64 ± 1. 31) d］， average hospitalization days ［( 7. 38 ± 2. 06) d］， and Chinese medicine syndrome scale score ［( 13. 29 ± 3. 79) points］ of the integrated treatment group were significantly lower than those in the western medicine group ( P ＜ 0. 05 or P ＜ 0. 01) ．When patients were discharged from hospital， the accompanying symptom disappearance rate ( 87. 9% ) ， the clinical cure rate ( 91. 2% ) ， and the incidence of common type patients developed to severe type ( 5. 9% ) in the integrated treatment group were significantly superior to those in the western medicine group ( the corresponding results 38. 9% ，61. 1% ， and 33. 3% respectively， P ＜ 0. 05 or P ＜ 0. 01) ． Conclusion The treatment of integrated Chinese and western medicine can significantly alleviate the clinical symptoms， shorten the course of disease and improve the cure rate， showing advantage to single use western medicine， which is worthy of clinical promotion and application
目的 回顾性分析52例新型冠状病毒肺炎患者的临床资料,探讨中西医结合治疗新型冠状病毒肺炎的临床疗效。方法 收集2020年1月15日—2020年2月8日在湖北省中西医结合医院出院的52例新型冠状病毒肺炎患者资料,对其基本信息、中医证候、实验室检查、治疗方法等进行调查分析,并对中西医结合治疗组(中西医组)(在西医组用药的基础上给予中药汤剂、中成药及中药针剂治疗)(34例)和西医组(18例)(给予西药抗病毒、抗感染、辅助支持药物)的临床症状消失时间、体温复常时间、其他症状消失率、平均住院天数、临床治愈率及死亡率等进行比较。结果 52例患者年龄(54.00±12.83)岁,男性44.2%,女性55.8%,发病到住院时间为(7.44±2.99)天,主要症状为:发热75%、乏力61.5%、咳嗽50%,其他症状34.6%
ABSTRACT
Objective To observe the novel coronavirus Qinggan Granule in treating pneumonia caused by new coronavirus infection. Methods one hundred and twenty-three patients with covid-19 were randomly divided into treatment group (treated with Jinhua Qinggan Granules Combined with conventional treatment) and control group (treated with conventional treatment only), with 82 cases in the treatment group and 41 cases in the control group, The clinical symptom disappearance rate, TCM Syndrome Scale score, hospitalization rate, Hamilton Anxiety Scale score, outpatient satisfaction score and incidence of adverse reactions were observed before and after treatment for 5 days. Results there was no significant difference in baseline data between the two groups. The disappearance rates of clinical symptoms in treatment group and control group were as follows: fever 80.3% and 53.1%, cachexia 80.8% and 81.3%, headache and body pain 77.8% and 66.7%, head and body weight 75.0% and 88.9%, fatigue 77.6% and 53.8%, cough 66.1% and 42.9%, expectoration 85.3% and 46.2%, sore throat 77.8% and 60.0%, pharyngitis 85.7% and 75.0%, dry throat 83.3% and 100.0%, nasal congestion and runny nose 87.5% and 66.7%, nausea and vomiting 83.3% and 71.4%. The hospitalization rate was 10.98% and 24.39% respectively, and the incidence of adverse reactions was 32.93% and 0. The disappearance rate of clinical fever, cough, fatigue, expectoration symptoms, TCM Syndrome Scale score and Hamilton Anxiety Scale score in the treatment group were significantly lower than those in the control group (P < 0.05 or P < 0.01), There was no significant difference in the hospitalization rate, the disappearance rate of chills, head and body pain, head and body weight, sore throat, itchy throat, dry throat, nasal congestion, runny nose, nausea and vomiting, and outpatient satisfaction score between the treatment group and the control group (P > 0.05), but the hospitalization rate was lower than that of the control group, The disappearance rate of head and body pain, sore throat, itchy throat, stuffy nose and runny nose, nausea and vomiting were higher than those in the control group. The disappearance rate of symptoms was higher in both groups. The novel coronavirus granule can significantly reduce the fever, cough, fatigue and expectoration of the new coronavirus pneumonia patients and relieve their psychological anxiety.
目的 观察金花清感颗粒治疗新型冠状病毒感染肺炎的临床疗效。方法 将123例COVID-19患者按照2:1随机分为治疗组(给予金花清感颗粒联合常规治疗)和对照组(仅给予常规治疗),其中治疗组82例,对照组41例,观察两组患者治疗前和治疗5天后的临床症状消失率、中医证候量表评分、住院率、汉密尔顿焦虑量表评分、门诊满意度评分及不良反应发生率。结果 两组患者基线资料比较差异无统计学意义。治疗组和对照组患者治疗后临床症状消失率:发热80.3%和53.1%,恶寒80.8%和81.3%,头身痛77.8%和66.7%,头身重75.0%和88.9%,乏力77.6%和53.8%,咳嗽66.1%和42.9%,咳痰85.3%和46.2%,咽痛77.8%和60.0%,咽痒85.7%和75.0%,咽干83.3%和100.0%,鼻塞流涕87.5%和66.7%,恶心呕吐83.3%和71.4%。住院率分别为10.98%和24.39%,不良反应发生率分别为32.93%和0。治疗组临床发热、咳嗽、乏力、咳痰症状消失率、中医证候量表评分、汉密尔顿焦虑量表评分均较对照组明显降低(P<0.05或P<0.01),治疗组住院率以及恶寒、头身痛、头身重、咽痛、咽痒、咽干、鼻塞流涕、恶心呕吐等症状消失率及门诊满意度评分与对照组比较差异无统计学意义(P>0.05),但住院率较对照组有降低趋势,而头身痛、咽痛、咽痒、鼻塞流涕、恶心呕吐等症状消失率较对照组有升高趋势。两组患者症状消失率均较高。结论 金花清感颗粒能显著减轻新型冠状病毒肺炎轻型患者的发热、咳嗽、乏力、咳痰临床症状,缓解患者心理焦虑。
ABSTRACT
Objective: To observe the clinical efficacy of Jinhua Qinggan Granule combined with conventional western medicine in the treatment of mild Coronavirus Disease 2019 (COVID-19). Methods: A total of 123 patients with COVID-19 were randomly divided into a treatment group of 82 cases giving Jinhua Qinggan Granule 6 g each time,3 times a day, combined with conventional western medicine treatment and a control group of 41 cases only conventional western medicine treatment. Both groups were treated for 5 day. The disappearance rate of clinical symptoms, hospitalization rate, before and after treatment TCM syndrome scale score, outpatient satisfaction, Hamilton anxiety scale, as well as adverse reaction rate of both groups were observed and compared. Results: The symptoms disappearance rate of patients in the treatment group and the control group after treatment was as following: fever 80. 3% and 53. 1%, fatigue 77. 6% and 53. 8%, cough 66. 1% and 42. 9%, expectoration 85. 3% and 46. 2%), the difference was statistically significant (P < 0. 05 or P < 0. 01). The hospitalization rate of the treatment group and the control group was 10. 98% and 24. 39% respectively, and the adverse reaction rate was 32. 93% and 0, respectively. After treatment, the scores of TCM Syndrome Scale and Hamilton Anxiety Scale of the treatment group were significantly lower than those of the control group (P < 0. 05 or P < 0. 01). There was no significant difference between groups in the hospitalization rate, symptom disappearance rate of chills, head and body pain, head and body weight, sore throat, sore itching, dry throat, nasal congestion and runny nose, nausea and vomiting and outpatient satisfaction scores (P > 0. 05). The adverse reaction rate of the treatment group was higher than that of the control group with significant difference (P < 0. 01). Conclusion: The treatment of Jinhua Qinggan Granule combined with conventional western medicine treatment can significantly alleviate the clinical symptoms of fever, cough, fatigue and expectoration in the mild patients, and relieve anxiety of the patients.
目的观察金花清感颗粒联合西医常规治疗方案治疗轻型新型冠状病毒肺炎(简称"新冠肺炎")的临床疗效。方法将123例新冠肺炎患者随机分为治疗组82例(给予金花清感颗粒每次6g,每日3次,联合西医常规治疗)和对照组41例(仅给予西医常规治疗),两组均治疗5天。观察两组患者的临床症状消失率、住院率,治疗前后中医证候量表评分、门诊满意度评分、汉密尔顿焦虑量表评分及不良反应发生情况。结果治疗组和对照组患者治疗后临床症状消失率分别为发热80.3%和53.1%,乏力77.6%和53.8%,咳嗽66.1%和42.9%,咳痰85.3%和46.2%,差异均有统计学意义(P<0.05或P<0.01)。治疗组和对照组住院率分别为10.98%和24.39%,不良反应发生率分别为32.93%和0。治疗后治疗组中医证候量表评分,汉密尔顿焦虑量表评分均明显低于对照组(P<0.05或P<0.01),治疗组住院率以及恶寒、头身痛、头身重、咽痛、咽痒、咽干、鼻塞流涕、恶心呕吐等症状消失率及门诊满意度评分与对照组比较差异无统计学意义(P>0.05)。治疗组不良反应发生率高于对照组,差异有统计学意义(P<0.01)。结论金花清感颗粒联合西医常规治疗方案能显著减轻轻型新冠肺炎患者的发热、咳嗽、乏力、咳痰临床症状,缓解患者焦虑情绪。
ABSTRACT
The clinical data of novel coronavirus pneumonia in the early and whole period from 2020 to March in 1 to March were analyzed. It was considered that the location of the disease was mainly in the lungs. It belonged to the damp and epidemic disease. The change of all kinds of diseases in different seasons was the inducement of the disease. The core pathogenesis was damp, toxic, heat, phlegm, stasis and deficiency. The treatment should combine disease differentiation and syndrome differentiation, and combine the severity of disease, the stage of disease course and TCM syndrome. Practice has proved that novel coronavirus, general lung dispersing, evil detoxification, dampness and detoxification, advanced heavy and early clearing blood and clearing blood stasis and dredging collaterals can improve the cure rate and reduce the incidence of severe coronavirus pneumonia, which is of certain value in reducing mortality.
综合分析2020年1至3月期间中医药早期、全程介入新型冠状病毒肺炎的临床救治资料，认为本病病位主要在肺，属于湿毒疫病，各地不同时令六淫的变化是疾病发生的诱因，核心病机为湿、毒、热、痰、瘀、虚；本病具有疫毒袭肺、壅肺、闭肺以及扰及心营等疫病病程发展的阶段性特点，治疗应辨病与辨证相结合，将疾病的病情轻重、病程分期与中医证候相结合。实践证明早期轻症、普通型宣肺透邪、化湿解毒，进展期重型及早清营凉血、化瘀通络，可以提高新型冠状病毒肺炎的治愈率、降低重症发生率，对于降低病死率有一定价值。
ABSTRACT
新型冠状病毒肺炎属于中医疫病范畴。通过对两则临床医案的辨析,认为其主要病机为湿毒为患,有寒湿和湿热之分,早期以寒湿为主,日久向湿热发展